Scarica l'app Stockscreener
37.88
4.27%
-1.69
Supernus Pharmaceuticals Inc Azioni (SUPN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
5.47%
219.06
|
207.71 | 211.57 | 192.10 | 165.45 |
| Cost Of Revenue |
43.94%
33.67
|
23.39 | 23.01 | 18.96 | 16.83 |
Selling, General, and Administrative
|
6.76%
133.64
|
125.17 | - | - | - |
| Costs And Expenses |
28.23%
277.02
|
216.04 | 215.51 | 252.33 | 153.31 |
| Depreciation and Amortization |
20.00%
0.40
|
0.50 | 0.50 | 0.50 | 0.50 |
| Operating Income/Loss |
595.67%
-57.96
|
-8.332 | -3.937 | -60.23 | 12.14 |
| Nonoperating Income/Loss |
86.78%
0.315
|
2.382 | 2.023 | 2.277 | 4.528 |
| Income/Loss From Continuing Operations Before Tax |
868.87%
-57.65
|
-5.95 | -1.914 | -57.95 | 16.67 |
| Income Tax Expense/Benefit, Deferred |
386.49%
-16.95
|
5.916 | 19.00 | -2.645 | -7.162 |
| Income Tax Expense/Benefit |
119.77%
0.723
|
-3.657 | 2.191 | -12.84 | -5.83 |
|
Net Income/Loss
|
2,446%
-58.37
|
-2.293 | -4.105 | -45.12 | 22.50 |
| Basic Average Shares |
0.73%
58.07
|
57.65 | 0.3172 | 56.55 | 56.02 |
| Diluted Average Shares |
0.73%
58.07
|
57.65 | 0.3172 | 56.55 | 56.64 |
| Basic Earnings Per Share |
2,425%
-1.01
|
-0.04 | -0.07 | -0.80 | 0.40 |
| Diluted Earnings Per Share |
2,425%
-1.01
|
-0.04 | -0.07 | -0.80 | 0.40 |
0.91%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):